Curocell

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.curocellbtx.com

Country

South Korea

Exchange

KOSDAQ

Founded 2016Daejeon, South Korea

Curocell Inc., a cell gene therapy development company provides the development and manufacturing of pharmaceuticals. It provides R&D services; and OVercome Immune Suppression (OVIS), a proprietary platform technology designed to get away from exhaustion induced by immune checkpoint receptors.

Founded in 2016, The company is also involved in the development of CD19 CAR-T treatment, blood cancer CAR-T, solid cancer CAR-T, and allogeneic CAR-T. Curocell is headquartered in Daejeon, South Korea.

Key Stats

52-Week Range

₩20750.00₩66000.00

Beta0.60

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.